General Pharmacology Open Access Journals
Study of the nature of the
drugs and how they react in the human body is general pharmacology. The final
drugs after several studies and clinical trials will be on the market and suggested by general physicians for various diseases. There are prescription
drugs that should be taken only under supervision of a general medicine doctor.The general
pharmacology is involves the aspects of sources of drugs, route of
administration of drugs, absorption of
drugs and factors affecting them, distribution,
biotransformation & its excretion and it also involves the mechanism by which drug is acting with receptor, toxicity of drug & preclinical and clinical evaluation.Pallor, jaundice, central cyanosis, peripheral cyanosis, pyrexia, dry, pitting edema, scratch marks, bruising, spider naevi etc. are some of the basic conditions where general
pharmacology is required. After knowing the condition of the patient after general diagnosis, immediate precautionary
drugs are general pharmacology. Mostly general
pharmacology drugs will become available everywhere & most reachable to the common people.
High Impact List of Articles
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
Study results suggest increasing disclosure in industry-sponsored clinical studies
News and Views: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Oncology studies tend to be smaller and less robust
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
Relevant Topics in Clinical